[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Atopic Dermatitis (Eczema) Treatment Market Growth 2022-2028

February 2022 | 101 pages | ID: GFCC1E5C2614EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Atopic Dermatitis (Eczema) Treatment will have significant change from previous year. According to our (LP Information) latest study, the global Atopic Dermatitis (Eczema) Treatment market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Atopic Dermatitis (Eczema) Treatment market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Atopic Dermatitis (Eczema) Treatment market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Atopic Dermatitis (Eczema) Treatment market, reaching US$ million by the year 2028. As for the Europe Atopic Dermatitis (Eczema) Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Atopic Dermatitis (Eczema) Treatment players cover Sanofi, Allergan, Novartis, and Bristol Myers Squibb, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Atopic Dermatitis (Eczema) Treatment market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
  • Topical
  • Oral
  • Injectable
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
  • Sanofi
  • Allergan
  • Novartis
  • Bristol Myers Squibb
  • Bayer
  • Meda Pharmaceuticals
  • Anacor Pharmaceutical
  • Pfizer
  • Astellas Pharma
  • Regeneron Pharmaceuticals
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Atopic Dermatitis (Eczema) Treatment Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Atopic Dermatitis (Eczema) Treatment by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Atopic Dermatitis (Eczema) Treatment by Country/Region, 2017, 2022 & 2028
2.2 Atopic Dermatitis (Eczema) Treatment Segment by Type
  2.2.1 Topical
  2.2.2 Oral
  2.2.3 Injectable
2.3 Atopic Dermatitis (Eczema) Treatment Sales by Type
  2.3.1 Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Type (2017-2022)
  2.3.2 Global Atopic Dermatitis (Eczema) Treatment Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Atopic Dermatitis (Eczema) Treatment Sale Price by Type (2017-2022)
2.4 Atopic Dermatitis (Eczema) Treatment Segment by Application
  2.4.1 Hospital Pharmacies
  2.4.2 Retail Pharmacies
  2.4.3 Online Pharmacies
2.5 Atopic Dermatitis (Eczema) Treatment Sales by Application
  2.5.1 Global Atopic Dermatitis (Eczema) Treatment Sale Market Share by Application (2017-2022)
  2.5.2 Global Atopic Dermatitis (Eczema) Treatment Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Atopic Dermatitis (Eczema) Treatment Sale Price by Application (2017-2022)

3 GLOBAL ATOPIC DERMATITIS (ECZEMA) TREATMENT BY COMPANY

3.1 Global Atopic Dermatitis (Eczema) Treatment Breakdown Data by Company
  3.1.1 Global Atopic Dermatitis (Eczema) Treatment Annual Sales by Company (2020-2022)
  3.1.2 Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Company (2020-2022)
3.2 Global Atopic Dermatitis (Eczema) Treatment Annual Revenue by Company (2020-2022)
  3.2.1 Global Atopic Dermatitis (Eczema) Treatment Revenue by Company (2020-2022)
  3.2.2 Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Company (2020-2022)
3.3 Global Atopic Dermatitis (Eczema) Treatment Sale Price by Company
3.4 Key Manufacturers Atopic Dermatitis (Eczema) Treatment Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Atopic Dermatitis (Eczema) Treatment Product Location Distribution
  3.4.2 Players Atopic Dermatitis (Eczema) Treatment Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR ATOPIC DERMATITIS (ECZEMA) TREATMENT BY GEOGRAPHIC REGION

4.1 World Historic Atopic Dermatitis (Eczema) Treatment Market Size by Geographic Region (2017-2022)
  4.1.1 Global Atopic Dermatitis (Eczema) Treatment Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Atopic Dermatitis (Eczema) Treatment Annual Revenue by Geographic Region
4.2 World Historic Atopic Dermatitis (Eczema) Treatment Market Size by Country/Region (2017-2022)
  4.2.1 Global Atopic Dermatitis (Eczema) Treatment Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Atopic Dermatitis (Eczema) Treatment Annual Revenue by Country/Region
4.3 Americas Atopic Dermatitis (Eczema) Treatment Sales Growth
4.4 APAC Atopic Dermatitis (Eczema) Treatment Sales Growth
4.5 Europe Atopic Dermatitis (Eczema) Treatment Sales Growth
4.6 Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales Growth

5 AMERICAS

5.1 Americas Atopic Dermatitis (Eczema) Treatment Sales by Country
  5.1.1 Americas Atopic Dermatitis (Eczema) Treatment Sales by Country (2017-2022)
  5.1.2 Americas Atopic Dermatitis (Eczema) Treatment Revenue by Country (2017-2022)
5.2 Americas Atopic Dermatitis (Eczema) Treatment Sales by Type
5.3 Americas Atopic Dermatitis (Eczema) Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Atopic Dermatitis (Eczema) Treatment Sales by Region
  6.1.1 APAC Atopic Dermatitis (Eczema) Treatment Sales by Region (2017-2022)
  6.1.2 APAC Atopic Dermatitis (Eczema) Treatment Revenue by Region (2017-2022)
6.2 APAC Atopic Dermatitis (Eczema) Treatment Sales by Type
6.3 APAC Atopic Dermatitis (Eczema) Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Atopic Dermatitis (Eczema) Treatment by Country
  7.1.1 Europe Atopic Dermatitis (Eczema) Treatment Sales by Country (2017-2022)
  7.1.2 Europe Atopic Dermatitis (Eczema) Treatment Revenue by Country (2017-2022)
7.2 Europe Atopic Dermatitis (Eczema) Treatment Sales by Type
7.3 Europe Atopic Dermatitis (Eczema) Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Atopic Dermatitis (Eczema) Treatment by Country
  8.1.1 Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Atopic Dermatitis (Eczema) Treatment Revenue by Country (2017-2022)
8.2 Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales by Type
8.3 Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Atopic Dermatitis (Eczema) Treatment
10.3 Manufacturing Process Analysis of Atopic Dermatitis (Eczema) Treatment
10.4 Industry Chain Structure of Atopic Dermatitis (Eczema) Treatment

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Atopic Dermatitis (Eczema) Treatment Distributors
11.3 Atopic Dermatitis (Eczema) Treatment Customer

12 WORLD FORECAST REVIEW FOR ATOPIC DERMATITIS (ECZEMA) TREATMENT BY GEOGRAPHIC REGION

12.1 Global Atopic Dermatitis (Eczema) Treatment Market Size Forecast by Region
  12.1.1 Global Atopic Dermatitis (Eczema) Treatment Forecast by Region (2023-2028)
  12.1.2 Global Atopic Dermatitis (Eczema) Treatment Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Atopic Dermatitis (Eczema) Treatment Forecast by Type
12.7 Global Atopic Dermatitis (Eczema) Treatment Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Sanofi
  13.1.1 Sanofi Company Information
  13.1.2 Sanofi Atopic Dermatitis (Eczema) Treatment Product Offered
  13.1.3 Sanofi Atopic Dermatitis (Eczema) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 Sanofi Main Business Overview
  13.1.5 Sanofi Latest Developments
13.2 Allergan
  13.2.1 Allergan Company Information
  13.2.2 Allergan Atopic Dermatitis (Eczema) Treatment Product Offered
  13.2.3 Allergan Atopic Dermatitis (Eczema) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 Allergan Main Business Overview
  13.2.5 Allergan Latest Developments
13.3 Novartis
  13.3.1 Novartis Company Information
  13.3.2 Novartis Atopic Dermatitis (Eczema) Treatment Product Offered
  13.3.3 Novartis Atopic Dermatitis (Eczema) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Novartis Main Business Overview
  13.3.5 Novartis Latest Developments
13.4 Bristol Myers Squibb
  13.4.1 Bristol Myers Squibb Company Information
  13.4.2 Bristol Myers Squibb Atopic Dermatitis (Eczema) Treatment Product Offered
  13.4.3 Bristol Myers Squibb Atopic Dermatitis (Eczema) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 Bristol Myers Squibb Main Business Overview
  13.4.5 Bristol Myers Squibb Latest Developments
13.5 Bayer
  13.5.1 Bayer Company Information
  13.5.2 Bayer Atopic Dermatitis (Eczema) Treatment Product Offered
  13.5.3 Bayer Atopic Dermatitis (Eczema) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 Bayer Main Business Overview
  13.5.5 Bayer Latest Developments
13.6 Meda Pharmaceuticals
  13.6.1 Meda Pharmaceuticals Company Information
  13.6.2 Meda Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Product Offered
  13.6.3 Meda Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 Meda Pharmaceuticals Main Business Overview
  13.6.5 Meda Pharmaceuticals Latest Developments
13.7 Anacor Pharmaceutical
  13.7.1 Anacor Pharmaceutical Company Information
  13.7.2 Anacor Pharmaceutical Atopic Dermatitis (Eczema) Treatment Product Offered
  13.7.3 Anacor Pharmaceutical Atopic Dermatitis (Eczema) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 Anacor Pharmaceutical Main Business Overview
  13.7.5 Anacor Pharmaceutical Latest Developments
13.8 Pfizer
  13.8.1 Pfizer Company Information
  13.8.2 Pfizer Atopic Dermatitis (Eczema) Treatment Product Offered
  13.8.3 Pfizer Atopic Dermatitis (Eczema) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.8.4 Pfizer Main Business Overview
  13.8.5 Pfizer Latest Developments
13.9 Astellas Pharma
  13.9.1 Astellas Pharma Company Information
  13.9.2 Astellas Pharma Atopic Dermatitis (Eczema) Treatment Product Offered
  13.9.3 Astellas Pharma Atopic Dermatitis (Eczema) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.9.4 Astellas Pharma Main Business Overview
  13.9.5 Astellas Pharma Latest Developments
13.10 Regeneron Pharmaceuticals
  13.10.1 Regeneron Pharmaceuticals Company Information
  13.10.2 Regeneron Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Product Offered
  13.10.3 Regeneron Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Sales, Revenue, Price and Gross Margin (2020-2022)
  13.10.4 Regeneron Pharmaceuticals Main Business Overview
  13.10.5 Regeneron Pharmaceuticals Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Atopic Dermatitis (Eczema) Treatment Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Atopic Dermatitis (Eczema) Treatment Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Topical
Table 4. Major Players of Oral
Table 5. Major Players of Injectable
Table 6. Global Atopic Dermatitis (Eczema) Treatment Sales by Type (2017-2022) & (K Units)
Table 7. Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Type (2017-2022)
Table 8. Global Atopic Dermatitis (Eczema) Treatment Revenue by Type (2017-2022) & ($ million)
Table 9. Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Type (2017-2022)
Table 10. Global Atopic Dermatitis (Eczema) Treatment Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Atopic Dermatitis (Eczema) Treatment Sales by Application (2017-2022) & (K Units)
Table 12. Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Application (2017-2022)
Table 13. Global Atopic Dermatitis (Eczema) Treatment Revenue by Application (2017-2022)
Table 14. Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Application (2017-2022)
Table 15. Global Atopic Dermatitis (Eczema) Treatment Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Atopic Dermatitis (Eczema) Treatment Sales by Company (2020-2022) & (K Units)
Table 17. Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Company (2020-2022)
Table 18. Global Atopic Dermatitis (Eczema) Treatment Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Company (2020-2022)
Table 20. Global Atopic Dermatitis (Eczema) Treatment Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Atopic Dermatitis (Eczema) Treatment Producing Area Distribution and Sales Area
Table 22. Players Atopic Dermatitis (Eczema) Treatment Products Offered
Table 23. Atopic Dermatitis (Eczema) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Atopic Dermatitis (Eczema) Treatment Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Atopic Dermatitis (Eczema) Treatment Sales Market Share Geographic Region (2017-2022)
Table 28. Global Atopic Dermatitis (Eczema) Treatment Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Atopic Dermatitis (Eczema) Treatment Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Country/Region (2017-2022)
Table 32. Global Atopic Dermatitis (Eczema) Treatment Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Atopic Dermatitis (Eczema) Treatment Sales by Country (2017-2022) & (K Units)
Table 35. Americas Atopic Dermatitis (Eczema) Treatment Sales Market Share by Country (2017-2022)
Table 36. Americas Atopic Dermatitis (Eczema) Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Country (2017-2022)
Table 38. Americas Atopic Dermatitis (Eczema) Treatment Sales by Type (2017-2022) & (K Units)
Table 39. Americas Atopic Dermatitis (Eczema) Treatment Sales Market Share by Type (2017-2022)
Table 40. Americas Atopic Dermatitis (Eczema) Treatment Sales by Application (2017-2022) & (K Units)
Table 41. Americas Atopic Dermatitis (Eczema) Treatment Sales Market Share by Application (2017-2022)
Table 42. APAC Atopic Dermatitis (Eczema) Treatment Sales by Region (2017-2022) & (K Units)
Table 43. APAC Atopic Dermatitis (Eczema) Treatment Sales Market Share by Region (2017-2022)
Table 44. APAC Atopic Dermatitis (Eczema) Treatment Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Region (2017-2022)
Table 46. APAC Atopic Dermatitis (Eczema) Treatment Sales by Type (2017-2022) & (K Units)
Table 47. APAC Atopic Dermatitis (Eczema) Treatment Sales Market Share by Type (2017-2022)
Table 48. APAC Atopic Dermatitis (Eczema) Treatment Sales by Application (2017-2022) & (K Units)
Table 49. APAC Atopic Dermatitis (Eczema) Treatment Sales Market Share by Application (2017-2022)
Table 50. Europe Atopic Dermatitis (Eczema) Treatment Sales by Country (2017-2022) & (K Units)
Table 51. Europe Atopic Dermatitis (Eczema) Treatment Sales Market Share by Country (2017-2022)
Table 52. Europe Atopic Dermatitis (Eczema) Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Country (2017-2022)
Table 54. Europe Atopic Dermatitis (Eczema) Treatment Sales by Type (2017-2022) & (K Units)
Table 55. Europe Atopic Dermatitis (Eczema) Treatment Sales Market Share by Type (2017-2022)
Table 56. Europe Atopic Dermatitis (Eczema) Treatment Sales by Application (2017-2022) & (K Units)
Table 57. Europe Atopic Dermatitis (Eczema) Treatment Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Atopic Dermatitis (Eczema) Treatment
Table 67. Key Market Challenges & Risks of Atopic Dermatitis (Eczema) Treatment
Table 68. Key Industry Trends of Atopic Dermatitis (Eczema) Treatment
Table 69. Atopic Dermatitis (Eczema) Treatment Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Atopic Dermatitis (Eczema) Treatment Distributors List
Table 72. Atopic Dermatitis (Eczema) Treatment Customer List
Table 73. Global Atopic Dermatitis (Eczema) Treatment Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Atopic Dermatitis (Eczema) Treatment Sales Market Forecast by Region
Table 75. Global Atopic Dermatitis (Eczema) Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Atopic Dermatitis (Eczema) Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Atopic Dermatitis (Eczema) Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Atopic Dermatitis (Eczema) Treatment Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Atopic Dermatitis (Eczema) Treatment Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Atopic Dermatitis (Eczema) Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Atopic Dermatitis (Eczema) Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Atopic Dermatitis (Eczema) Treatment Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Atopic Dermatitis (Eczema) Treatment Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Atopic Dermatitis (Eczema) Treatment Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Atopic Dermatitis (Eczema) Treatment Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Atopic Dermatitis (Eczema) Treatment Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Atopic Dermatitis (Eczema) Treatment Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share Forecast by Application (2023-2028)
Table 93. Sanofi Basic Information, Atopic Dermatitis (Eczema) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi Atopic Dermatitis (Eczema) Treatment Product Offered
Table 95. Sanofi Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Sanofi Main Business
Table 97. Sanofi Latest Developments
Table 98. Allergan Basic Information, Atopic Dermatitis (Eczema) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 99. Allergan Atopic Dermatitis (Eczema) Treatment Product Offered
Table 100. Allergan Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Allergan Main Business
Table 102. Allergan Latest Developments
Table 103. Novartis Basic Information, Atopic Dermatitis (Eczema) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 104. Novartis Atopic Dermatitis (Eczema) Treatment Product Offered
Table 105. Novartis Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Novartis Main Business
Table 107. Novartis Latest Developments
Table 108. Bristol Myers Squibb Basic Information, Atopic Dermatitis (Eczema) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 109. Bristol Myers Squibb Atopic Dermatitis (Eczema) Treatment Product Offered
Table 110. Bristol Myers Squibb Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Bristol Myers Squibb Main Business
Table 112. Bristol Myers Squibb Latest Developments
Table 113. Bayer Basic Information, Atopic Dermatitis (Eczema) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 114. Bayer Atopic Dermatitis (Eczema) Treatment Product Offered
Table 115. Bayer Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Bayer Main Business
Table 117. Bayer Latest Developments
Table 118. Meda Pharmaceuticals Basic Information, Atopic Dermatitis (Eczema) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 119. Meda Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Product Offered
Table 120. Meda Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Meda Pharmaceuticals Main Business
Table 122. Meda Pharmaceuticals Latest Developments
Table 123. Anacor Pharmaceutical Basic Information, Atopic Dermatitis (Eczema) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 124. Anacor Pharmaceutical Atopic Dermatitis (Eczema) Treatment Product Offered
Table 125. Anacor Pharmaceutical Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Anacor Pharmaceutical Main Business
Table 127. Anacor Pharmaceutical Latest Developments
Table 128. Pfizer Basic Information, Atopic Dermatitis (Eczema) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 129. Pfizer Atopic Dermatitis (Eczema) Treatment Product Offered
Table 130. Pfizer Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Pfizer Main Business
Table 132. Pfizer Latest Developments
Table 133. Astellas Pharma Basic Information, Atopic Dermatitis (Eczema) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 134. Astellas Pharma Atopic Dermatitis (Eczema) Treatment Product Offered
Table 135. Astellas Pharma Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Astellas Pharma Main Business
Table 137. Astellas Pharma Latest Developments
Table 138. Regeneron Pharmaceuticals Basic Information, Atopic Dermatitis (Eczema) Treatment Manufacturing Base, Sales Area and Its Competitors
Table 139. Regeneron Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Product Offered
Table 140. Regeneron Pharmaceuticals Atopic Dermatitis (Eczema) Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Regeneron Pharmaceuticals Main Business
Table 142. Regeneron Pharmaceuticals Latest Developments

LIST OF FIGURES

Figure 1. Picture of Atopic Dermatitis (Eczema) Treatment
Figure 2. Atopic Dermatitis (Eczema) Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Atopic Dermatitis (Eczema) Treatment Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Atopic Dermatitis (Eczema) Treatment Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Atopic Dermatitis (Eczema) Treatment Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Topical
Figure 10. Product Picture of Oral
Figure 11. Product Picture of Injectable
Figure 12. Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Type in 2021
Figure 13. Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Type (2017-2022)
Figure 14. Atopic Dermatitis (Eczema) Treatment Consumed in Hospital Pharmacies
Figure 15. Global Atopic Dermatitis (Eczema) Treatment Market: Hospital Pharmacies (2017-2022) & (K Units)
Figure 16. Atopic Dermatitis (Eczema) Treatment Consumed in Retail Pharmacies
Figure 17. Global Atopic Dermatitis (Eczema) Treatment Market: Retail Pharmacies (2017-2022) & (K Units)
Figure 18. Atopic Dermatitis (Eczema) Treatment Consumed in Online Pharmacies
Figure 19. Global Atopic Dermatitis (Eczema) Treatment Market: Online Pharmacies (2017-2022) & (K Units)
Figure 20. Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Application (2017-2022)
Figure 21. Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Application in 2021
Figure 22. Atopic Dermatitis (Eczema) Treatment Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Company in 2021
Figure 24. Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Geographic Region in 2021
Figure 26. Global Atopic Dermatitis (Eczema) Treatment Sales Market Share by Region (2017-2022)
Figure 27. Global Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Country/Region in 2021
Figure 28. Americas Atopic Dermatitis (Eczema) Treatment Sales 2017-2022 (K Units)
Figure 29. Americas Atopic Dermatitis (Eczema) Treatment Revenue 2017-2022 ($ Millions)
Figure 30. APAC Atopic Dermatitis (Eczema) Treatment Sales 2017-2022 (K Units)
Figure 31. APAC Atopic Dermatitis (Eczema) Treatment Revenue 2017-2022 ($ Millions)
Figure 32. Europe Atopic Dermatitis (Eczema) Treatment Sales 2017-2022 (K Units)
Figure 33. Europe Atopic Dermatitis (Eczema) Treatment Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Revenue 2017-2022 ($ Millions)
Figure 36. Americas Atopic Dermatitis (Eczema) Treatment Sales Market Share by Country in 2021
Figure 37. Americas Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Country in 2021
Figure 38. United States Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Atopic Dermatitis (Eczema) Treatment Sales Market Share by Region in 2021
Figure 43. APAC Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Regions in 2021
Figure 44. China Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Atopic Dermatitis (Eczema) Treatment Sales Market Share by Country in 2021
Figure 51. Europe Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Country in 2021
Figure 52. Germany Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Atopic Dermatitis (Eczema) Treatment Revenue Market Share by Country in 2021
Figure 59. Egypt Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Atopic Dermatitis (Eczema) Treatment Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Atopic Dermatitis (Eczema) Treatment in 2021
Figure 65. Manufacturing Process Analysis of Atopic Dermatitis (Eczema) Treatment
Figure 66. Industry Chain Structure of Atopic Dermatitis (Eczema) Treatment
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles


More Publications